Boothbay Fund Management, LLC Relmada Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $5.7 Billion
  • Q3 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$18.3 - $37.02 $1.8 Million - $3.64 Million
98,200 Added 256.4%
136,500 $5.05 Million
Q2 2022

Aug 15, 2022
BUY
$16.5 - $30.34 $631,950 - $1.16 Million
38,300 New
38,300 $727,000
Q3 2021

Nov 15, 2021
SELL
$21.86 - $34.77 $513,710 - $817,095
-23,500 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$29.55 - $39.15 $694,425 - $920,025
23,500 New
23,500 $752,000

Others Institutions Holding RLMD

# of Institutions
51
Shares Held
7.88M
Call Options Held
84.3K
Put Options Held
0
View Full List

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $113M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email